SGMT

Sagimet Biosciences Stock Analysis

AI Rating

Neutral
  • Quality5/10
  • Growth↓ 2/10
  • Value↑ 5/10
Sagimet Biosciences sales and earnings growth
SGMT Growth
Fair
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↓ -8.97%
  • FCF Y/Y↓ -7.58%
Sagimet Biosciences gross and profit margin trends
SGMT Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC 5Y↓ 0.00%
Sagimet Biosciences net debt vs free cash flow
SGMT Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↑ 999.0

Sagimet Biosciences stock volatility is higher than the overall market. We give it a Great risk rating.

More Biotechnology stocks ↗